<unk>  is a monoclonal antibody that is FDA approved for the treatment of Adult Ulcerative Colitis and Crohn’s disease.   Common adverse reactions include nasopharyngitis and fatigue.
Vedolizumab
Mepolizumab
Certolizumab pegol
Belatacept
Natalizumab
Basiliximab
Infliximab
Abatacept